A Partnership for the Future of Human Medicine

The partnership with Octapharma AG is a source of great mutual enrichment.
Octapharma AG is a company that is active worldwide founded in 1983, specializing in the development and production of preparations from human plasma. The emphasis is on extremely pure, virus-deactivated medicines to be used for immunology, hematology, and intensive care.

With more than 4,000 employees in more than 50 countries and four modern branch facilities in Germany, Austria, Sweden, and France, Octapharma AG has positioned itself at the forefront of the global market.

Cooperation in the Name of Progress

Further cooperation with science and industry worldwide make it possible to access the most modern technologies. This also ensures the international exchange of experiences and know-how, and these discoveries are channeled directly into our research and development. This contributes to progress in medicine and science as well as to the improvement of the life conditions of patients.